Scarica l'app Stockscreener
10.97
3.81%
-0.445
Carlsmed Inc Borsa (CARL) Ultime notizie
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - The Manila Times
Carlsmed completes first surgery using aprevo bilateral posterior system By Investing.com - Investing.com Nigeria
Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure - Orthopedics This Week
Carlsmed completes first surgery using aprevo bilateral posterior system - Investing.com
Both private equity firms who control a good portion of Carlsmed, Inc. (NASDAQ:CARL) along with institutions must be dismayed after last week's 11% decrease - simplywall.st
TD Waterhouse Canada Inc. Takes $2.03 Million Position in Carlsmed, Inc. $CARL - MarketBeat
Teacher Retirement System of Texas Purchases Shares of 175,000 Carlsmed, Inc. $CARL - MarketBeat
Financial Comparison: Carlsmed (NASDAQ:CARL) & ReShape Lifesciences (OTCMKTS:RSLSD) - Defense World
Bullish Carlsmed Insiders Loaded Up On US$8.10m Of Stock - Yahoo Finance
Analyzing Carlsmed (NASDAQ:CARL) and Perspective Therapeutics (NASDAQ:CATX) - Defense World
Carlsmed (NASDAQ:CARL) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
BTIG Reiterates Buy Rating on CARL, Maintains Price Target | CAR - GuruFocus
AI medtech firm Carlsmed prices $100.5M IPO - MSN
California-based Carlsmed Q4 2025 revenue up 61% to USD 15.2M - Medical Buyer
Carlsmed reports 61% revenue growth in Q4 2025 By Investing.com - Investing.com Nigeria
Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025 - Ortho Spine News
Carlsmed reports 61% revenue growth in Q4 2025 - Investing.com
More surgeons turn to AI-enabled spine surgery tech as Carlsmed grows - Stock Titan
Carlsmed, Inc.'s Lock-Up Period Set To End on January 19th (NASDAQ:CARL) - MarketBeat
Carlsmed, Inc.’s Lock-Up Period Set To End on January 19th (NASDAQ:CARL) - Defense World
Top Carlsmed (CARL) Competitors 2026 - MarketBeat
Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal - Ortho Spine News
Carlsmed’s personalized implants reduce spine surgery reoperations By Investing.com - Investing.com Nigeria
Carlsmed’s personalized implants reduce spine surgery reoperations - Investing.com
What is the current Price Target and Forecast for Carlsmed, Inc. (CARL) - Zacks Investment Research
Carlsmed Debuts AI-based Custom Implants for Cervical Spine Surgery - San Diego Business Journal
Critical Comparison: Longevity Health (NASDAQ:XAGE) vs. Carlsmed (NASDAQ:CARL) - Defense World
Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference - The Manila Times
Inside the J.P. Morgan healthcare event Carlsmed is joining in 2026 - Stock Titan
BTIG Reiterates Carlsmed (CARL) Buy Recommendation - Nasdaq
Carlsmed stock holds Buy rating at BTIG as aprevo Cervical launch shows promise By Investing.com - Investing.com South Africa
Carlsmed stock holds Buy rating at BTIG as aprevo Cervical launch shows promise - Investing.com Nigeria
CARLSMED, INC. (CARL) Competitors - Meyka
CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery - Yahoo Finance
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting - Ortho Spine News
Carlsmed launches personalized cervical fusion implant system By Investing.com - Investing.com Nigeria
Carlsmed Launches Aprevo Platform for Cervical Fusion Surgeries - marketscreener.com
Carlsmed launches personalized cervical fusion implant system - Investing.com
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting - GlobeNewswire Inc.
Comparing Bioventus (NASDAQ:BVS) & Carlsmed (NASDAQ:CARL) - Defense World
10.56%
4.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):